Virogin Biotech aims to be a global, best-in-class oncolytic virus company that creates impactful drugs for patients of the highest medical need. Our platform technology focuses on creating long-lasting antitumor immunity by capitalizing on a robust, transient antiviral immune response through a synergy with multiple payload expression. Virogin is designing a more potent oncolytic virus, expressing optimized payloads to enhance the systemic antitumor immunity in relapsed/refractory cancers. Led by our leadership team with over 25 years of experience in fundamental research, translational and clinical development of immunotherapy & oncolytic virotherapy, we are determined to bring our novel therapies for relapsed/refractory cancers to market.
Looking for a particular Virogin Biotech employee's phone or email?
Virogin Biotech Questions
The Virogin Biotech annual revenue was $10.6 million in 2026.
Chris Huang is the Chief Executive Officer and Co-Founder of Virogin Biotech.
24 people are employed at Virogin Biotech.
Virogin Biotech is based in Richmond, British Columbia.
The NAICS codes for Virogin Biotech are [5417, 54, 541713, 54171, 541].
The SIC codes for Virogin Biotech are [873, 87].
Top Virogin Biotech Employees
-
2
-
William Jia
Chief Scientific Officer at Virogin Biotech
Vancouver, BC, CA11 -
25+
-
William Jia
Co-founder and Chief Scientific Officer at Virogin Biotech
Vancouver, BC, CA1 -
Sarah Chen
Financial Controller at Virogin Biotech
Vancouver, BC, CA2 -
Miriam
Human Resources Director at Virogin Biotech
Shanghai, China -
Victor Xiao
Medical Director at Virogin Biotech
Markham, ON, CA2
Related Companies
